Literature DB >> 21868379

Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells.

Florence Gizard1, Yue Zhao, Hannes M Findeisen, Hua Qing, Dianne Cohn, Elizabeth B Heywood, Karrie L Jones, Takashi Nomiyama, Dennis Bruemmer.   

Abstract

Members of the NR4A subgroup of the nuclear hormone receptor superfamily have emerged as key transcriptional regulators of proliferation and inflammation. NOR1 constitutes a ligand-independent transcription factor of this subgroup and induces cell proliferation; however, the transcriptional mechanisms underlying this mitogenic role remain to be defined. Here, we demonstrate that the F-box protein SKP2 (S phase kinase-associated protein 2), the substrate-specific receptor of the ubiquitin ligase responsible for the degradation of p27(KIP1) through the proteasome pathway, constitutes a direct transcriptional target for NOR1. Mitogen-induced Skp2 expression is silenced in vascular smooth muscle cells (VSMC) isolated from Nor1-deficient mice or transfected with Nor1 siRNA. Conversely, adenovirus-mediated overexpression of NOR1 induces Skp2 expression in VSMC and decreases protein abundance of its target p27. Transient transfection experiments establish that NOR1 transactivates the Skp2 promoter through a nerve growth factor-induced clone B response element (NBRE). Electrophoretic mobility shift and chromatin immunoprecipitation assays further revealed that NOR1 is recruited to this NBRE site in the Skp2 promoter in response to mitogenic stimulation. In vivo Skp2 expression is increased during the proliferative response underlying neointima formation, and this transcriptional induction depends on the expression of NOR1. Finally, we demonstrate that overexpression of Skp2 rescues the proliferative arrest of Nor1-deficient VSMC. Collectively, these results characterize Skp2 as a novel NOR1-regulated target gene and detail a previously unrecognized transcriptional cascade regulating mitogen-induced VSMC proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868379      PMCID: PMC3195596          DOI: 10.1074/jbc.M111.295840

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Skp2-mediated degradation of p27 regulates progression into mitosis.

Authors:  Keiko Nakayama; Hiroyasu Nagahama; Yohji A Minamishima; Satoshi Miyake; Noriko Ishida; Shigetsugu Hatakeyama; Masatoshi Kitagawa; Shun-ichiro Iemura; Tohru Natsume; Keiichi I Nakayama
Journal:  Dev Cell       Date:  2004-05       Impact factor: 12.270

Review 3.  The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells.

Authors:  José Martínez-González; Lina Badimon
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

4.  Identification of the DNA binding site for NGFI-B by genetic selection in yeast.

Authors:  T E Wilson; T J Fahrner; M Johnston; J Milbrandt
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

5.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

Authors:  R Gallo; A Padurean; T Jayaraman; S Marx; M Roque; S Adelman; J Chesebro; J Fallon; V Fuster; A Marks; J J Badimon
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

6.  F-box protein Skp2: a novel transcriptional target of E2F.

Authors:  L Zhang; C Wang
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

7.  3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).

Authors:  U Laufs; D Marra; K Node; J K Liao
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.

Authors:  H Zhang; R Kobayashi; K Galaktionov; D Beach
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.

Authors:  V Fantl; G Stamp; A Andrews; I Rosewell; C Dickson
Journal:  Genes Dev       Date:  1995-10-01       Impact factor: 11.361

Review 10.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

View more
  11 in total

1.  A Novel Angiotensin II-Induced Long Noncoding RNA Giver Regulates Oxidative Stress, Inflammation, and Proliferation in Vascular Smooth Muscle Cells.

Authors:  Sadhan Das; Erli Zhang; Parijat Senapati; Vishnu Amaram; Marpadga A Reddy; Kenneth Stapleton; Amy Leung; Linda Lanting; Mei Wang; Zhuo Chen; Mitsuo Kato; Hyung Jung Oh; Qianyun Guo; Xinyue Zhang; Bin Zhang; Haitong Zhang; Qinghao Zhao; Wei Wang; Yongjian Wu; Rama Natarajan
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

2.  Epigenetic regulation of the NR4A orphan nuclear receptor NOR1 by histone acetylation.

Authors:  Yue Zhao; Takashi Nomiyama; Hannes M Findeisen; Hua Qing; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Dennis Bruemmer
Journal:  FEBS Lett       Date:  2014-11-21       Impact factor: 4.124

3.  The C. elegans NR4A nuclear receptor gene nhr-6 promotes cell cycle progression in the spermatheca lineage.

Authors:  Brandon Praslicka; Chris R Gissendanner
Journal:  Dev Dyn       Date:  2015-01-24       Impact factor: 3.780

4.  Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.

Authors:  Hua Qing; Yi Liu; Yue Zhao; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Deborah Howatt; Cassi M Binkley; Alan Daugherty; Ying Liang; Dennis Bruemmer
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

5.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

6.  A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B.

Authors:  Joshua M Boucher; Anne Harrington; Bahman Rostama; Volkhard Lindner; Lucy Liaw
Journal:  Circ Res       Date:  2013-08-21       Impact factor: 17.367

7.  BINDING SITE ANALYSIS OF THE CAENORHABDITIS ELEGANS NR4A NUCLEAR RECEPTOR NHR-6 DURING DEVELOPMENT.

Authors:  Brandon Praslicka; Jeremy S Harmson; Joohyun Kim; Vittobai Rashika Rangaraj; Aikseng Ooi; Chris R Gissendanner
Journal:  Nucl Receptor Res       Date:  2017-07-23

8.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

9.  The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation.

Authors:  Beatriz Ferrán; Ingrid Martí-Pàmies; Judith Alonso; Ricardo Rodríguez-Calvo; Silvia Aguiló; Francisco Vidal; Cristina Rodríguez; José Martínez-González
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

10.  The association of neuron-derived orphan receptor 1 with pulmonary vascular remodeling in COPD patients.

Authors:  Chang-Guo Wang; Chang Li; Wei Lei; Jun-Hong Jiang; Jian-An Huang; Da-Xiong Zeng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.